Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 107INDUSTRY 11OTHER_GOV 4UNKNOWN 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 2Breast 2Head & Neck 1Genitourinary 1

Conditions

Esophageal Squamous Cell Carcinoma 2Liver Neoplasms 1Chemotherapy 1

Interventions

Oxaliplatin 30Capecitabine 26Fluorouracil 20Irinotecan 19tislelizumab 18apatinib 16Paclitaxel 13Cisplatin 13S 1 (combination) 12Radiotherapy 12Leucovorin 11Bevacizumab 11Laparoscopy 9Drug Therapy 9Cetuximab 9sintilimab 8Endoscopic Mucosal Resection 8Radiation 7Gemcitabine 7Docetaxel 7camrelizumab 6XELOX 6Surgical Procedures, Operative 6Propranolol 6Nivolumab 6Neoadjuvant Therapy 6Immune Checkpoint Inhibitors 6Folfox protocol 6Levoleucovorin 5HMPL-013 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × toripalimab × Gastrointestinal × Clear all
NCT07629817 2026-06-05

HCHTOG2603

Henan Cancer Hospital

Phase 3 Not yet recruiting
1,044 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04891016 2024-06-06

Toripalimab Plus FLOT in Locally Advanced Gastric Cancer

Henan Cancer Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Chemotherapy

NCT05162898 2022-01-27

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Henan Cancer Hospital

Phase NA Unknown
90 enrolled
Gastrointestinal

Liver Neoplasms

NCT04229849 2020-01-18

Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma

Henan Cancer Hospital

Phase 2 Unknown
164 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡